Signal Transduction Practice Questions

Q: Oxytocin causes muscle contraction through which mechanism?

IP3-DAG. **Explanation:** Oxytocin exerts its physiological effects (primarily uterine contraction and milk ejection) by binding to the **Oxytocin Receptor (OXTR)**, which is a member of the **G-protein coupled receptor (GPCR)** family, specifically coupled to the **Gq subclass**. 1. **Mechanism of Action (Why C is correct):** When oxytocin binds to its receptor, it activates **Phospholipase C (PLC)**. PLC cleaves the membrane phospholipid Phosphatidylinositol 4,5-bisphosphate (PIP2) into two second messengers: * **Inositol triphosphate (IP3):** Binds to receptors on the sarcoplasmic reticulum, causing a rapid release of **intracellular Calcium (Ca²⁺)**. * **Diacylglycerol (DAG):** Activates Protein Kinase C (PKC). The surge in intracellular calcium binds to calmodulin, activating Myosin Light Chain Kinase (MLCK), which leads to smooth muscle contraction. 2. **Why other options are incorrect:** * **A (cAMP):** This is the second messenger for Gs/Gi-coupled receptors (e.g., Glucagon, ACTH, ADH-V2). cAMP typically causes smooth muscle *relaxation* (e.g., Beta-2 agonists). * **B (Ion channels):** While calcium enters via channels, the *primary* signal transduction for the oxytocin receptor is metabolic (GPCR), not a direct ligand-gated ion channel (like Nicotinic ACh receptors). * **D (Nuclear receptors):** These are used by lipid-soluble hormones (Steroids, Thyroid hormones, Vitamin D) that act as transcription factors. Oxytocin is a peptide hormone and cannot cross the cell membrane. **High-Yield Clinical Pearls for NEET-PG:** * **Gq-coupled receptors mnemonic:** "**HAV 1 M&M**" (H1, Alpha-1, V1-ADH, M1, M3) and **Oxytocin**. * **V1 vs. V2:** ADH acts via **Gq (IP3-DAG)** on V1 receptors (vasoconstriction) but via **Gs (cAMP)** on V2 receptors (renal water reabsorption). * Oxytocin is synthesized in the **paraventricular nucleus** of the hypothalamus and stored in the posterior pituitary.

Q: Patients with both Graves' disease and Cushing syndrome are overproducing hormones that have which one of the following in common?

Binding to intracellular receptors. **Explanation:** The core of this question lies in identifying the signaling mechanisms of the specific hormones involved in Graves' disease and Cushing syndrome. **1. Why the Correct Answer is Right:** * **Graves’ Disease** involves the overproduction of **Thyroid Hormones (T3, T4)**. * **Cushing Syndrome** involves the overproduction of **Glucocorticoids (Cortisol)**. Both Thyroid hormones and Steroid hormones are lipophilic. They cross the plasma membrane and **bind to intracellular receptors** (Cortisol binds to cytoplasmic receptors which then translocate; T3/T4 bind directly to nuclear receptors). These hormone-receptor complexes act as transcription factors, binding to Hormone Response Elements (HRE) on DNA to regulate gene expression. **2. Why the Incorrect Options are Wrong:** * **Option A & B:** These describe the mechanism for **water-soluble hormones** (e.g., Catecholamines, Peptides like Insulin or Glucagon). These hormones cannot cross the lipid bilayer and must bind to cell membrane receptors, often triggering second messengers like cAMP, IP3/DAG, or cGMP. * **Option D:** Hormone-receptor complexes bind to **DNA**, not RNA. They stimulate or inhibit the transcription of DNA into mRNA, which is then translated into proteins. **Clinical Pearls for NEET-PG:** * **Nuclear Receptors (Group I):** Steroids (Cortisol, Aldosterone, Estrogen, Progesterone, Testosterone), Thyroid hormones (T3/T4), Retinoic acid, and Vitamin D. * **Mnemonic for Intracellular Receptors:** "PET TV" (Progesterone, Estrogen, Testosterone, Thyroid, Vitamin D/Vitamin A). * **Graves' Disease:** Caused by Thyroid Stimulating Immunoglobulins (TSI) mimicking TSH. * **Cushing Syndrome:** Characterized by hypercortisolism; remember that Cortisol is the "stress hormone" from the adrenal cortex.

Q: Which of the following hormones does NOT involve calcium as a second messenger in its action?

Insulin. **Explanation:** The mechanism of hormone action is determined by the type of receptor it binds to. Hormones that utilize **Calcium/Phospholipase C (PLC)** as a second messenger system typically bind to G-protein coupled receptors (GPCRs), specifically the **Gq subtype**. **1. Why Insulin is the correct answer:** Insulin does not use calcium or cAMP as a second messenger. Instead, it acts through an **Enzyme-linked receptor** (specifically, a **Receptor Tyrosine Kinase**). Upon insulin binding, the receptor undergoes autophosphorylation, which activates Insulin Receptor Substrates (IRS-1/2) and the PI3K/AKT pathway. This pathway is responsible for the translocation of GLUT-4 transporters to the cell membrane. **2. Why the other options are incorrect:** * **Gastrin:** Acts via Gq-coupled receptors on parietal cells and ECL cells to increase intracellular calcium, stimulating HCl secretion. * **Oxytocin:** Utilizes the Gq-PLC-IP3/DAG pathway to increase intracellular calcium, which is essential for smooth muscle contraction in the uterus (labor) and mammary glands (milk let-down). * **ADH (Vasopressin):** While ADH uses cAMP via **V2 receptors** in the kidney, it uses the **Calcium/IP3 pathway** via **V1 receptors** to cause systemic vasoconstriction. Since it *does* involve calcium in its V1 action, it is not the correct choice here. **High-Yield NEET-PG Pearls:** * **Tyrosine Kinase Pathway:** Remember the mnemonic **"PIG"** (Prolactin, Insulin, Growth Hormone) for hormones using kinase-related receptors (though Prolactin/GH use the JAK-STAT variant). * **Gq-coupled (Calcium) mnemonic:** **"GOAT HAG"** (GnRH, Oxytocin, ADH (V1), TRH, Histamine (H1), Angiotensin II, Gastrin). * **cAMP-mediated:** FSH, LH, ACTH, TSH, Glucagon, and ADH (V2).

Q: To which end of the G protein-coupled receptor are the G proteins attached?

Carboxyterminal end. **Explanation:** G-protein-coupled receptors (GPCRs) are **seven-transmembrane (serpentine)** proteins that cross the lipid bilayer seven times. The structural orientation is critical for their function: 1. **Why Option B is Correct:** The **Carboxy-terminal (C-terminus)** and the **third intracellular loop (IL3)** are located on the **cytosolic side** of the plasma membrane. Heterotrimeric G-proteins ($\alpha, \beta, \gamma$ subunits) are peripheral membrane proteins anchored to the inner leaflet of the plasma membrane. Therefore, the G-protein binds to the intracellular domains of the receptor, specifically the C-terminus and the IL3, to initiate signal transduction upon ligand binding. 2. **Why Other Options are Incorrect:** * **Option A (Amino-terminal end):** The N-terminus is located on the **extracellular side**. Its primary role is often involved in ligand binding (especially for peptide hormones) and receptor trafficking, not G-protein coupling. * **Options C & D (Transmembrane domains):** The 3rd and 7th transmembrane domains are hydrophobic segments embedded within the lipid bilayer. While they form the structural core and the ligand-binding pocket (for small molecules like epinephrine), they do not directly "attach" to the G-protein, which resides in the aqueous environment of the cytosol. **High-Yield Clinical Pearls for NEET-PG:** * **Molecular Switch:** G-proteins act as switches; they are **active when bound to GTP** and inactive when bound to GDP. * **Termination:** The intrinsic **GTPase activity** of the $\alpha$-subunit hydrolyzes GTP to GDP, terminating the signal. * **Toxins:** *Vibrio cholerae* toxin causes permanent activation of $G_s$ (by ADP-ribosylation), leading to persistent cAMP elevation and secretory diarrhea. * **Second Messengers:** GPCRs typically work through cAMP (via Adenylyl Cyclase) or $IP_3/DAG$ (via Phospholipase C).

Q: IP3 facilitates which ion entry into the cytoplasm?

Ca++. **Explanation:** The correct answer is **C. Ca++**. **Mechanism of Action:** In the Phosphoinositide signaling pathway, a ligand binds to a G-protein coupled receptor (GPCR), activating Phospholipase C (PLC). PLC cleaves the membrane phospholipid Phosphatidylinositol 4,5-bisphosphate (PIP2) into two second messengers: **Diacylglycerol (DAG)** and **Inositol 1,4,5-trisphosphate (IP3)**. IP3 is water-soluble and diffuses into the cytoplasm, where it binds to specific **IP3-gated Calcium channels** located on the membrane of the **Endoplasmic Reticulum (ER)** (or Sarcoplasmic Reticulum in muscles). This binding triggers the opening of these channels, allowing stored Ca++ ions to flow down their concentration gradient into the cytoplasm. Increased cytosolic Ca++ then activates various cellular processes, often by binding to Calmodulin. **Analysis of Incorrect Options:** * **A (Na+) & B (K+):** These ions are primarily involved in maintaining membrane potential and nerve impulse conduction via voltage-gated or ligand-gated channels (like the Nicotinic ACh receptor), but they are not directly regulated by the IP3 second messenger system. * **D (Mg++):** Magnesium acts as a cofactor for many enzymes (especially those involving ATP), but it does not serve as a primary signaling ion released by the IP3 pathway. **High-Yield Clinical Pearls for NEET-PG:** * **DAG vs. IP3:** While IP3 releases Ca++, DAG remains in the membrane to activate **Protein Kinase C (PKC)**. * **Lithium Connection:** Lithium, used in Bipolar Disorder, inhibits the recycling of Inositol (Inositol monophosphatase), thereby depleting PIP2 levels and dampening this signaling pathway. * **H1, α1, V1, M1, M3:** These receptors (mnemonic: "HAV 1 M&M") all utilize the Gq-PLC-IP3-Ca++ pathway.

Q: All of the following hormones use cyclic AMP as a second messenger except?

Estrogen. **Explanation:** The core concept tested here is the classification of hormones based on their chemical nature and receptor location. **1. Why Estrogen is the correct answer:** Hormones are broadly divided into two groups. **Group I hormones** (Steroids, Thyroid hormones, Calcitriol, and Retinoids) are lipophilic. They cross the cell membrane and bind to **intracellular or nuclear receptors**. Their mechanism of action involves changing gene expression directly rather than using second messengers. **Estrogen**, being a steroid hormone, follows this mechanism and does not utilize cAMP. **2. Why the other options are incorrect:** Options A, C, and D are **Group II hormones**. These are water-soluble (peptides or catecholamines) and cannot cross the lipid bilayer. They bind to cell surface receptors (G-Protein Coupled Receptors - GPCRs) and activate the **Adenylyl Cyclase system**, which converts ATP to **cAMP** (the second messenger). * **Glucagon:** Uses cAMP to trigger glycogenolysis in the liver. * **Epinephrine:** Acts via $\beta$-adrenergic receptors to increase cAMP. * **Luteinizing Hormone (LH):** A glycoprotein hormone that uses cAMP to stimulate steroidogenesis in gonads. **Clinical Pearls for NEET-PG:** * **Mnemonic for cAMP-mediated hormones:** "FLAT ChAMP" (FSH, LH, ACTH, TSH, CRH, hCG, ADH (V2), MSH, PTH) + Glucagon and Calcitonin. * **ANP and Nitric Oxide (NO)** use **cGMP** as a second messenger. * **Insulin and Growth Hormone** use the **Tyrosine Kinase** pathway. * **Oxytocin and GnRH** use the **IP3/DAG** (Calcium) pathway.

Q: Which of the following hormones does not utilize cAMP as a second messenger?

Insulin. **Explanation:** The correct answer is **Insulin**. The mechanism of action for hormones depends on their receptor type and the specific second messenger system they activate. **1. Why Insulin is the correct answer:** Insulin (along with IGF-1 and Growth Hormone) utilizes the **Receptor Tyrosine Kinase (RTK)** pathway rather than the cAMP pathway. Upon binding to its α-subunits, the β-subunits undergo autophosphorylation, activating **Insulin Receptor Substrates (IRS-1/2)**. This triggers the PI3K/Akt pathway and the MAP kinase pathway to regulate glucose uptake and gene expression. It does not involve Adenylate Cyclase or cAMP. **2. Why the other options are incorrect:** * **TSH, LH, and FSH:** These are all glycoprotein hormones secreted by the anterior pituitary. They bind to **G-Protein Coupled Receptors (GPCRs)** linked to the **Gs protein**. This activates Adenylate Cyclase, which converts ATP to **cAMP**, subsequently activating Protein Kinase A (PKA). Therefore, they all utilize cAMP as their primary second messenger. **High-Yield Clinical Pearls for NEET-PG:** * **cAMP Users (FLAT ChAMP):** **F**SH, **L**H, **A**CTH, **T**SH, **C**RH, **h**CG, **A**DH (V2 receptor), **M**SH, **P**TH, and Glucagon. * **cGMP Users:** ANP, BNP, and Nitric Oxide (Vasodilators). * **IP3/DAG Users (GOAT):** **G**nRH, **O**xytocin, **A**DH (V1 receptor), **T**RH. * **Tyrosine Kinase (Intrinsic):** Insulin, IGF-1, PDGF. * **JAK/STAT (Non-intrinsic TK):** Growth Hormone, Prolactin, Erythropoietin.

Q: FSH, LH, and TSH act through which mechanism?

Cyclic AMP. **Explanation:** The hormones **FSH (Follicle-Stimulating Hormone), LH (Luteinizing Hormone), and TSH (Thyroid-Stimulating Hormone)**, along with ACTH and Glucagon, utilize the **G-protein coupled receptor (GPCR) – Adenylate Cyclase pathway**. When these hormones bind to their specific membrane receptors, they activate the Gs-protein, which in turn stimulates the enzyme Adenylate Cyclase. This enzyme converts ATP into **Cyclic AMP (cAMP)**, which acts as the **second messenger** to activate Protein Kinase A (PKA), leading to the desired cellular response. **Analysis of Options:** * **Option A (Correct):** cAMP is the definitive second messenger for these glycoprotein hormones. * **Option B (Incorrect):** Cyclic GMP (cGMP) is the second messenger for Atrial Natriuretic Peptide (ANP) and Nitric Oxide (NO). * **Option C (Incorrect):** While Adenylate Cyclase is involved in the pathway, it is the **effector enzyme**, not the second messenger itself. The question asks for the mechanism/messenger through which they act. * **Option D (Incorrect):** Calcium/IP3/DAG pathways are utilized by hormones like Oxytocin, TRH, and GnRH (the "Gq" protein pathway). **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic for cAMP:** "FLAT ChAMP" (FSH, LH, ACTH, TSH, CRH, hCG, ADH (V2 receptor), MSH, PTH). * **Mnemonic for IP3/DAG:** "GOAT" (GnRH, Oxytocin, ADH (V1 receptor), TRH). * **Insulin and Growth Factors** primarily use **Receptor Tyrosine Kinase** pathways. * **Steroid and Thyroid hormones** (T3/T4) act via **Intracellular/Nuclear receptors** because they are lipophilic.

Q: Where are receptors of glucocorticoids typically located?

Cytosol. **Explanation:** **1. Why Cytosol is Correct:** Glucocorticoids (like cortisol) are lipophilic steroid hormones that easily diffuse across the lipid bilayer of the cell membrane. Once inside the cell, they bind to **Glucocorticoid Receptors (GR)**, which are primarily located in the **cytosol**. In their inactive state, these receptors are bound to **Heat Shock Proteins (HSP-90)**, which mask the receptor's DNA-binding domain. Upon ligand binding, the HSP dissociates, and the hormone-receptor complex dimerizes and translocates into the nucleus to act as a transcription factor. **2. Why Other Options are Incorrect:** * **DNA:** While the hormone-receptor complex eventually binds to specific DNA sequences called **Glucocorticoid Response Elements (GREs)**, the receptor itself is not "located" on the DNA in its basal state. * **Nucleus:** This is the location for receptors of **Thyroid hormones (T3/T4)**, Retinoic acid, and Vitamin D. Unlike glucocorticoids, these receptors are already bound to DNA even in the absence of a ligand. (Note: Estrogen and Progesterone receptors are also primarily nuclear). * **Cell Surface:** This is the site for water-soluble ligands (e.g., Peptide hormones like Insulin, Catecholamines) that cannot cross the cell membrane and require secondary messengers. **3. NEET-PG High-Yield Pearls:** * **Mnemonic for Receptor Location:** * **C**ytosolic: **C**ortisol (Glucocorticoids), Aldosterone (Mineralocorticoids). * **N**uclear: **N**on-steroids like Thyroid hormone, Vitamin D, and Retinoic acid. * **Mechanism:** Glucocorticoids regulate gene expression via **Zinc-finger motifs** in their DNA-binding domain. * **Clinical Link:** The dissociation of HSP-90 is a crucial step for receptor activation; drugs targeting HSPs are currently being researched for various endocrine disorders.

Q: Which of the following is NOT a secondary messenger?

Plasmalogen. **Explanation:** **1. Why Plasmalogen is the Correct Answer:** Plasmalogens are a specific class of **ether phospholipids** found abundantly in the myelin sheath of the brain and the membranes of the heart. They are **structural components** of cell membranes rather than signaling molecules. Unlike secondary messengers, they do not relay signals from receptors to target molecules within the cell. **2. Analysis of Incorrect Options (Secondary Messengers):** * **cAMP (Cyclic Adenosine Monophosphate):** The most common secondary messenger, activated by Adenylyl Cyclase. it primarily activates Protein Kinase A (PKA). * **cGMP (Cyclic Guanosine Monophosphate):** Produced by Guanylyl Cyclase, it mediates the effects of Nitric Oxide (NO) and Atrial Natriuretic Peptide (ANP). It activates Protein Kinase G (PKG). * **IP3 (Inositol Trisphosphate):** Derived from the cleavage of PIP2 by Phospholipase C (PLC). It binds to receptors on the Endoplasmic Reticulum to trigger the release of **Calcium (Ca²⁺)**, which is also a major secondary messenger. **3. High-Yield Clinical Pearls for NEET-PG:** * **Zellweger Syndrome:** A peroxisomal disorder characterized by the inability to synthesize plasmalogens, leading to severe neurological deficits. * **DAG (Diacylglycerol):** Often paired with IP3; it remains in the membrane to activate Protein Kinase C (PKC). * **Receptor Tyrosine Kinases (RTK):** These (e.g., Insulin receptor) often bypass traditional secondary messengers by using phosphorylation cascades (MAPK pathway). * **Memory Trick:** Common secondary messengers include **cAMP, cGMP, IP3, DAG, and Ca²⁺.** If it’s a structural lipid or a primary hormone, it is NOT a secondary messenger.

Question 1

Oxytocin causes muscle contraction through which mechanism?

Accepted Answer

IP3-DAG

Answer

cAMP

Answer

Ion channels

Answer

Nuclear receptors

Question 2

Patients with both Graves' disease and Cushing syndrome are overproducing hormones that have which one of the following in common?

Accepted Answer

Binding to intracellular receptors

Answer

Reacting with receptors in the cell membrane

Answer

Utilizing second messengers

Answer

Binding to RNA to produce physiologically active proteins

Question 3

Which of the following hormones does NOT involve calcium as a second messenger in its action?

Accepted Answer

Insulin

Answer

Gastrin

Answer

Oxytocin

Answer

ADH

Question 4

To which end of the G protein-coupled receptor are the G proteins attached?

Accepted Answer

Carboxyterminal end

Answer

Aminoterminal end

Answer

Third transmembrane domain

Answer

Seventh transmembrane domain

Question 5

IP3 facilitates which ion entry into the cytoplasm?

Accepted Answer

Ca++

Answer

Na+

Answer

K+

Answer

Mg++

Question 6

All of the following hormones use cyclic AMP as a second messenger except?

Accepted Answer

Estrogen

Answer

Glucagon

Answer

Epinephrine

Answer

Luteinizing hormone

Question 7

Which of the following hormones does not utilize cAMP as a second messenger?

Accepted Answer

Insulin

Answer

TSH

Answer

LH

Answer

FSH

Question 8

FSH, LH, and TSH act through which mechanism?

Accepted Answer

Cyclic AMP

Answer

Cyclic GMP

Answer

Adenylate cyclase

Answer

Calcium release

Question 9

Where are receptors of glucocorticoids typically located?

Accepted Answer

Cytosol

Answer

DNA

Answer

Nucleus

Answer

Cell surface

Question 10

Which of the following is NOT a secondary messenger?

Accepted Answer

Plasmalogen

Answer

cAMP

Answer

cGMP

Answer

IP3

Signal Transduction — MCQs

Signal Transduction — MCQs

On this page

Practice by Chapter

Want unlimited practice?